Resideo Announces Third Quarter 2021 Financial Results
Resideo Technologies, Inc. (NYSE: REZI) reported a 10% increase in third-quarter revenue, reaching $1.5 billion, with a gross profit margin of 27.8%. Operating profit surged to $167 million, and cash from operations increased to $104 million. However, net income fell to $68 million, or $0.46 per diluted share. For 2021, Resideo revised its revenue outlook to $5.83 billion - $5.88 billion and projected fourth-quarter revenue between $1.44 billion - $1.49 billion, citing supply chain challenges impacting demand fulfillment.
- Revenue grew 10% to $1.5 billion.
- Operating profit increased to $167 million.
- Cash flow from operations rose to $104 million.
- Gross profit margin improved to 27.8%.
- Net income decreased to $68 million from $75 million.
- Products & Solutions gross profit margin decreased to 40.9%.
- Supply chain and logistics challenges constrain meeting customer demand.
AUSTIN, Texas, Nov. 4, 2021 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global provider of home comfort and security solutions and distributor of commercial and residential security and audio-visual products, today announced financial and operating results for the third quarter ended October 2, 2021.
Third Quarter 2021 Highlights
- Net revenue of
$1.5 billion , up10% from$1.4 billion in the third quarter 2020 - Gross profit margin of
27.8% , up 60 basis points compared to gross profit margin of27.2% in the prior year comparable period - Operating profit of
$167 million , or11.2% of revenue, an increase of$36 million from$131 million , or9.6% of revenue, in the third quarter 2020 - Cash provided by operating activities of
$104 million compared to$21 million in the prior year comparable period
Third Quarter 2021 Performance
Consolidated revenue of
Gross profit margin for the third quarter 2021 was
Resideo's operating profit of
Net income for the third quarter 2021 was
Cash Flow and Liquidity
The company reported net cash provided by operating activities of
Outlook
The company today updated its outlook for 2021 and now expects full year revenue to be in the range of
The company expects fourth quarter 2021 revenue to be in the range of
Management Remarks
"We delivered another quarter of strong growth and profitability expansion as we continue to execute on our business transformation," commented Jay Geldmacher, Resideo's president and CEO. "End customer demand remains healthy across our businesses, but our ability to fully meet this demand is being constrained by ongoing supply chain and logistics challenges.
"We have made significant progress on our transformation efforts, with a number of benefits visible in our results. Our revenue growth is well outpacing our spending, even as we invest in key long-term growth initiatives. ADI delivered meaningful expansion in gross and operating margin aided by ongoing investments in tools to support pricing and digital transactions. Within Products & Solutions, supply constraints and inflationary pressures are muting progress on productivity enhancements."
Conference Call and Webcast Details
Resideo will hold a conference call with investors on November 4, 2021, at 5:00 p.m. ET. An audio webcast of the call will be accessible at https://investor.resideo.com, where related materials will be posted before the call. A replay of the webcast will be available following the presentation. To join the conference call, please dial 888-660-6357 (U.S. toll-free) or 1-929-201-6127 (international), with the conference title "Resideo Third Quarter 2021 Earnings" or the conference ID: 7301399.
About Resideo
Resideo is a leading global manufacturer and distributor of technology-driven products and solutions that provide comfort, security, energy efficiency and control to customers worldwide. Building on a 130-year heritage, Resideo has a presence in more than 150 million homes, with 15 million systems installed in homes each year. We continue to serve more than 110,000 professionals through leading distributors, including our ADI Global Distribution business, which exports to more than 100 countries from nearly 200 stocking locations around the world. For more information about Resideo, please visit www.resideo.com.
Contacts: | |
Investors: | Media: |
Jason Willey | Oliver Clark |
Forward-Looking Statements
This release contains "forward-looking statements." All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties, and other factors, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, (1) the duration and severity of the COVID-19 pandemic and the disruption to our business and the global economy caused by it, including (A) its effect on the demand for our products and services, (B) its effect on our and our business partners' supply chains, workforce, liquidity, spending and timing for payments and disbursements, and (C) the impact of potential facility closures and the modified working conditions at our corporate offices, Product & Solutions segment and ADI Global Distribution segment, (2) the amount of our obligations and nature of our contractual restrictions pursuant to, and disputes that have or may hereafter arise under, the agreements we entered into with Honeywell in connection with our spin-off, (3) the likelihood of continued success of our transformation programs and initiatives, (4) whether the settlement of our pending securities class action litigation will become effective and finally approved by the court on the terms previously announced, and (5) the other risks described under the headings "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" in our Annual Report on Form 10-K for the year ended December 31, 2020 and other periodic filings we make from time to time with the Securities and Exchange Commission (SEC). You are cautioned not to place undue reliance on these forward-looking statements, such as (i) the outlook regarding fourth quarter 2021 and full year 2021 and (ii) the impact of the COVID-19 pandemic on our business and operations. Forward-looking statements are not guarantees of future performance, and actual results, developments, and business decisions may differ from those envisaged by our forward-looking statements. Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances arising after the date of this press release, and we caution investors not to place undue reliance on any such forward-looking statements.
Table 1: SUMMARY OF FINANCIAL RESULTS (UNAUDITED) | |||||||||||||||||||||||||
Q3 2021 | YTD 2021 | ||||||||||||||||||||||||
Products | ADI Global | Corporate | Total | Products | ADI Global | Corporate | Total | ||||||||||||||||||
Revenue (1) | $ | 631 | $ | 865 | $ | - | $ | 1,496 | $ | 1,835 | $ | 2,557 | $ | - | $ | 4,392 | |||||||||
Cost of goods sold | 373 | 705 | 2 | 1,080 | 1,116 | 2,105 | 6 | 3,227 | |||||||||||||||||
Gross profit (loss) | 258 | 160 | (2) | 416 | 719 | 452 | (6) | 1,165 | |||||||||||||||||
Selling, general and | 81 | 87 | 61 | 229 | 241 | 254 | 189 | 684 | |||||||||||||||||
Research and development | 20 | - | - | 20 | 62 | - | 1 | 63 | |||||||||||||||||
Operating profit (loss) | $ | 157 | $ | 73 | $ | (63) | $ | 167 | $ | 416 | $ | 198 | $ | (196) | $ | 418 | |||||||||
Q3 2020 | YTD 2020 | ||||||||||||||||||||||||
Products | ADI Global | Corporate | Total | Products | ADI Global | Corporate | Total | ||||||||||||||||||
Revenue (1) | $ | 572 | $ | 790 | $ | - | $ | 1,362 | $ | 1,445 | $ | 2,125 | $ | - | $ | 3,570 | |||||||||
Cost of goods sold | 330 | 660 | 2 | 992 | 907 | 1,768 | 5 | 2,680 | |||||||||||||||||
Gross profit (loss) | 242 | 130 | (2) | 370 | 538 | 357 | (5) | 890 | |||||||||||||||||
Selling, general and | 83 | 74 | 64 | 221 | 244 | 222 | 210 | 676 | |||||||||||||||||
Research and development | 18 | - | - | 18 | 53 | - | 2 | 55 | |||||||||||||||||
Operating profit (loss) | $ | 141 | $ | 56 | $ | (66) | $ | 131 | $ | 241 | $ | 135 | $ | (217) | $ | 159 | |||||||||
Q3 2021 % change compared with prior period | YTD 2021 % change compared with prior period | ||||||||||||||||||||||||
Products | ADI Global | Corporate | Total | Products | ADI Global | Corporate | Total | ||||||||||||||||||
Revenue (1) | 10 | % | 9 | % | N/A | 10 | % | 27 | % | 20 | % | N/A | 23 | % | |||||||||||
Cost of goods sold | 13 | % | 7 | % | 0 | % | 9 | % | 23 | % | 19 | % | 20 | % | 20 | % | |||||||||
Gross profit (loss) | 7 | % | 23 | % | 0 | % | 12 | % | 34 | % | 27 | % | 20 | % | 31 | % | |||||||||
Selling, general and | (2) | % | 18 | % | (5) | % | 4 | % | (1) | % | 14 | % | (10) | % | 1 | % | |||||||||
Research and development | 11 | % | N/A | N/A | 11 | % | 17 | % | N/A | (50) | % | 15 | % | ||||||||||||
Operating profit (loss) | 11 | % | 30 | % | (5) | % | 27 | % | 73 | % | 47 | % | (10) | % | 163 | % | |||||||||
(1) Represents Product & Solutions revenue, excluding intersegment revenue of | |||||||||||||||||||||||||
(2) Prior year information was reclassified to present Research and development expenses as a separate line item. Research and development expenses were formerly included within Selling, general and administrative expenses. |
Table 2: CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (UNAUDITED) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
October 2, | September 26, | October 2, | September 26, | |||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(In millions except share and per share data) | ||||||||||||||||
Net revenue | $ | 1,496 | $ | 1,362 | $ | 4,392 | $ | 3,570 | ||||||||
Cost of goods sold | 1,080 | 992 | 3,227 | 2,680 | ||||||||||||
Gross profit | 416 | 370 | 1,165 | 890 | ||||||||||||
Selling, general and administrative | 229 | 221 | 684 | 676 | ||||||||||||
Research and development expenses (1) | 20 | 18 | 63 | 55 | ||||||||||||
Operating profit | 167 | 131 | 418 | 159 | ||||||||||||
Other expense, net | 58 | 35 | 130 | 106 | ||||||||||||
Interest expense | 12 | 14 | 37 | 49 | ||||||||||||
Income before taxes | 97 | 82 | 251 | 4 | ||||||||||||
Tax expense | 29 | 7 | 76 | 26 | ||||||||||||
Net income (loss) | $ | 68 | $ | 75 | $ | 175 | $ | (22) | ||||||||
Weighted Average Number of | ||||||||||||||||
Basic | 144,284 | 123,421 | 143,865 | 123,194 | ||||||||||||
Diluted | 148,559 | 125,235 | 148,260 | 123,194 | ||||||||||||
Earnings (Loss) Per Share | ||||||||||||||||
Basic | $ | 0.47 | $ | 0.61 | $ | 1.22 | $ | (0.18) | ||||||||
Diluted | $ | 0.46 | $ | 0.60 | $ | 1.18 | $ | (0.18) | ||||||||
1) The prior year unaudited Consolidated Interim Statements of Operations were reclassified to present Research and development expenses as a separate line item within the statements. Research and development expenses were formerly included within Selling, general and administrative expenses. |
Table 3: CONSOLIDATED BALANCE SHEETS (UNAUDITED) | ||||||||
October 2, | December 31, | |||||||
2021 | 2020 | |||||||
(In millions, except number of | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 686 | $ | 517 | ||||
Accounts receivables – net | 932 | 863 | ||||||
Inventories – net | 710 | 672 | ||||||
Other current assets | 179 | 173 | ||||||
Total current assets | 2,507 | 2,225 | ||||||
Property, plant and equipment – net | 290 | 318 | ||||||
Goodwill | 2,671 | 2,691 | ||||||
Other assets | 366 | 376 | ||||||
Total assets | $ | 5,834 | $ | 5,610 | ||||
LIABILITIES | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 905 | $ | 936 | ||||
Current maturities of long-term debt | 10 | 7 | ||||||
Accrued liabilities | 617 | 595 | ||||||
Total current liabilities | 1,532 | 1,538 | ||||||
Long-term debt | 1,222 | 1,155 | ||||||
Obligations payable under Indemnification Agreements | 587 | 590 | ||||||
Other liabilities | 335 | 334 | ||||||
EQUITY | ||||||||
Common stock, | - | - | ||||||
Additional paid-in capital | 2,111 | 2,070 | ||||||
Treasury stock, at cost | (16) | (6) | ||||||
Retained earnings | 250 | 75 | ||||||
Accumulated other comprehensive loss | (187) | (146) | ||||||
Total equity | 2,158 | 1,993 | ||||||
Total liabilities and equity | $ | 5,834 | $ | 5,610 |
Table 4: CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
October 2, | September 26, | October 2, | September 26, | ||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
(In millions) | |||||||||||||||
Cash flows provided by operating | |||||||||||||||
Net income (loss) | $ | 68 | $ | 75 | $ | 175 | $ | (22) | |||||||
Adjustments to reconcile net income (loss) | |||||||||||||||
Depreciation and amortization | 22 | 22 | 67 | 64 | |||||||||||
Stock compensation expense | 10 | 7 | 29 | 21 | |||||||||||
Loss on extinguishment of debt | 18 | - | 41 | - | |||||||||||
Other | 9 | (1) | 4 | 20 | |||||||||||
Changes in assets and liabilities, net of | |||||||||||||||
Accounts receivable | (45) | (177) | (78) | (64) | |||||||||||
Inventories – net | (32) | 6 | (40) | 64 | |||||||||||
Other current assets | 18 | 2 | (6) | 15 | |||||||||||
Accounts payable | (4) | 47 | (19) | (62) | |||||||||||
Accrued liabilities | 36 | 38 | 26 | 52 | |||||||||||
Obligations payable under Indemnification | 3 | 1 | (3) | (8) | |||||||||||
Other | 1 | 1 | 7 | 12 | |||||||||||
Net cash provided by operating activities | 104 | 21 | 203 | 92 | |||||||||||
Cash flows used for investing activities: | |||||||||||||||
Expenditures for property, plant, equipment | (13) | (19) | (48) | (50) | |||||||||||
Cash paid for acquisitions, net of cash | (1) | - | (11) | (35) | |||||||||||
Other | - | - | 3 | - | |||||||||||
Net cash used for investing activities | (14) | (19) | (56) | (85) | |||||||||||
Cash flows provided by (used for) | |||||||||||||||
Proceeds from long-term debt | 300 | - | 1,250 | - | |||||||||||
Payment of debt facility issuance and | (18) | - | (39) | - | |||||||||||
Net proceeds from revolving credit facility | - | (100) | - | 150 | |||||||||||
Repayment of long-term debt | (262) | (5) | (1,185) | (11) | |||||||||||
Other | 1 | (1) | 2 | (4) | |||||||||||
Net cash provided by (used for) financing | 21 | (106) | 28 | 135 | |||||||||||
Effect of foreign exchange rate changes on | (4) | 2 | (6) | (4) | |||||||||||
Net increase (decrease) in cash and cash | 107 | (102) | 169 | 138 | |||||||||||
Cash and cash equivalents at beginning of | 579 | 362 | 517 | 122 | |||||||||||
Cash and cash equivalents at end of period | $ | 686 | $ | 260 | $ | 686 | $ | 260 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/resideo-announces-third-quarter-2021-financial-results-301416951.html
SOURCE Resideo Technologies, Inc.
FAQ
What were Resideo's Q3 2021 earnings results for REZI?
How did Resideo's revenue compare in Q3 2021 versus Q3 2020?
What is Resideo's outlook for full-year 2021 revenue?